Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein - PubMed (original) (raw)

Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein

S J Leevers et al. EMBO J. 1992 Feb.

Abstract

To examine signal transduction events activated by oncogenic p21ras, we have studied kinases that are activated following the scrape loading of p21ras into quiescent cells. We observe rapid activation of 42 kDa and 46 kDa protein kinases. The 42 kDa kinase is the mitogen and extracellular-signal regulated kinase ERK2, (MAP2 kinase), which is activated by phosphorylation on tyrosine and threonine in response to oncogenic p21ras, while the 46 kDa kinase is likely to be another member of the ERK family. Stimulation of these kinases by oncogenic p21ras does not require the presence of growth factors, showing that oncogenic p21ras uncouples kinase activation from external signals. In ras transformed cell lines, these kinases are constitutively activated. We propose that the kinases are important components of the signal transduction pathway activated by p21ras oncoprotein.

PubMed Disclaimer

Similar articles

• cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor.
  Burgering BM, Pronk GJ, van Weeren PC, Chardin P, Bos JL. Burgering BM, et al. EMBO J. 1993 Nov;12(11):4211-20. doi: 10.1002/j.1460-2075.1993.tb06105.x. EMBO J. 1993. PMID: 8223435 Free PMC article.
• PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity.
  Qui MS, Green SH. Qui MS, et al. Neuron. 1992 Oct;9(4):705-17. doi: 10.1016/0896-6273(92)90033-a. Neuron. 1992. PMID: 1382473
• Activation of p70/p85 S6 kinase by a pathway independent of p21ras.
  Ming XF, Burgering BM, Wennström S, Claesson-Welsh L, Heldin CH, Bos JL, Kozma SC, Thomas G. Ming XF, et al. Nature. 1994 Sep 29;371(6496):426-9. doi: 10.1038/371426a0. Nature. 1994. PMID: 8090223
• A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras.
  Schaap D, van der Wal J, Howe LR, Marshall CJ, van Blitterswijk WJ. Schaap D, et al. J Biol Chem. 1993 Sep 25;268(27):20232-6. J Biol Chem. 1993. PMID: 8397201
• Regulation of platelet-derived growth factor signaling by activated p21Ras.
  Stice LL, Vaziri C, Faller DV. Stice LL, et al. Front Biosci. 1999 Jan 15;4:D72-86. doi: 10.2741/stice. Front Biosci. 1999. PMID: 9889183 Review.

Cited by

• Unravelling molecular dynamics in living cells: Fluorescent protein biosensors for cell biology.
  Sanchez C, Ramirez A, Hodgson L. Sanchez C, et al. J Microsc. 2024 Feb 15:10.1111/jmi.13270. doi: 10.1111/jmi.13270. Online ahead of print. J Microsc. 2024. PMID: 38357769
• Robust mapping of spatiotemporal trajectories and cell-cell interactions in healthy and diseased tissues.
  Pham D, Tan X, Balderson B, Xu J, Grice LF, Yoon S, Willis EF, Tran M, Lam PY, Raghubar A, Kalita-de Croft P, Lakhani S, Vukovic J, Ruitenberg MJ, Nguyen QH. Pham D, et al. Nat Commun. 2023 Nov 25;14(1):7739. doi: 10.1038/s41467-023-43120-6. Nat Commun. 2023. PMID: 38007580 Free PMC article.
• Mechanically sensitive HSF1 is a key regulator of left-right symmetry breaking in zebrafish embryos.
  Du J, Li SK, Guan LY, Guo Z, Yin JF, Gao L, Kawanishi T, Shimada A, Zhang QP, Zheng LS, Liu YY, Feng XQ, Zhao L, Chen DY, Takeda H, Fan YB. Du J, et al. iScience. 2023 Sep 9;26(10):107864. doi: 10.1016/j.isci.2023.107864. eCollection 2023 Oct 20. iScience. 2023. PMID: 37766982 Free PMC article.
• U0126: Not only a MAPK kinase inhibitor.
  You Y, Niu Y, Zhang J, Huang S, Ding P, Sun F, Wang X. You Y, et al. Front Pharmacol. 2022 Aug 25;13:927083. doi: 10.3389/fphar.2022.927083. eCollection 2022. Front Pharmacol. 2022. PMID: 36091807 Free PMC article. Review.
• Kinase inhibitors: look beyond the label on the bottle.
  Dent P, Poklepovic A, Booth L, Hancock JF. Dent P, et al. Cancer Drug Resist. 2019 Dec 19;2(4):1032-1043. doi: 10.20517/cdr.2019.80. eCollection 2019. Cancer Drug Resist. 2019. PMID: 35582272 Free PMC article. Review.

References

1. 1. J Biol Chem. 1991 Mar 5;266(7):4220-7 - PubMed
2. 1. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4981-5 - PubMed
3. 1. Nature. 1991 May 9;351(6322):122-7 - PubMed
4. 1. Cell. 1991 May 17;65(4):663-75 - PubMed
5. 1. EMBO J. 1990 Jan;9(1):171-80 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • PubMed Central
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal